Updated on 5 February 2026
Next-generation allogeneic CAR T-cell immunotherapies for acute myeloid leukemia
International Projects Manager INiBICA at INiBICA – Institute for Biomedical Research of Cádiz
Cadiz, Spain
About
The INiBICA (Instituto de Investigación e Innovación Biomédica de Cádiz) is a public biomedical research institute with strong activity in translational medicine and advanced therapies. Within INiBICA, the immunotherapy group led by Francisco García Cózar focuses on the development of innovative allogeneic CAR T-cell strategies, particularly for acute myeloid leukemia (AML).
The group develops flexible, off-the-shelf CAR T platforms and novel antibody-based targeting approaches aimed at improving efficacy while reducing toxicity. Their work combines target identification, advanced preclinical modeling, and close interaction with clinical hematology, enabling effective translation from laboratory research to clinical application.
Topic
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
Similar opportunities
Project cooperation
Psychology clinical research team from Institute of Biomedical Research and Innovation of Cádiz
- Completing the consortia
- Offering Expertise to Consortias
- Design - setting the project scope
- Ideation - identifying the project idea
- Drafting - writing the project proposal
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
Juan Mougan Navarro
International Projects Manager INiBICA at INiBICA – Institute for Biomedical Research of Cádiz
Cadiz, Spain
Project cooperation
Expertise in stakeholders engagement and knowledge translation
- HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
- HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
- HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Ana Ferreira
European Grants Manager at Beyond Data
Aveiro, Portugal
Project cooperation
SME biotech partner offering integrated genomic and epigenomic profiling for early cancer prediction
- Offering Expertise to Consortias
- HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
- HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
- HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Ana Pou
Project Manager at Aniling
Barcelona, Spain